Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces a breakthrough with the launch of the latest mineral – free addition to the label friendly Nutrafinish® P Film Coatings for the nutritional and dietary supplements market.
Consumers continue to call for products with ingredient lists that are easy to understand and only contain materials they view as of “natural” origin. Manufacturers are looking to satisfy these consumer needs with sustainable ingredients that can achieve label friendly status while not compromising on product quality, manufacturing efficiency, or cost-in-use.
Colorcon leads the evolution in coating products for dietary supplements by bringing to the market mineralfree Nutrafinish, Label Friendly Coatings that satisfy consumer desires and meet manufacturer’s needs, without adversely affecting tablet appearance. The latest addition to the Nutrafinish, label friendly product line is formulated without the use of TiO2, talc and calcium carbonate to deliver a high level of opacity to cover unsightly or dark tablet cores.
Kelly Boyer, Vice President Film Coatings explains: “The launch of Colorcon’s new mineral-free formulations provides the nutritional market with alternative coating systems that combines superior opacity with excellent stability especially when using non-synthetic colorants. This product line expansion includes a new white formulation, which delivers superior opacity and the option to pigment using non-synthetic colors enables a broad choice of the color palette to provide aesthetics and brand differentiation”.
Dr. Ali Rajabi-Siahboomi adds: “Getting the right balance of components for this type of coatings is challenging without the use of opacity and whitening ingredients like TiO2 and calcium carbonate. Through Colorcon’s in-depth knowledge of materials and coating technology, these new formulations provide simple preparation and use, with the label friendly claims the industry and consumers are demanding; along with a perfectly finished tablet.”
Through its extensive portfolio of fully formulated coatings Colorcon provides scope for customers to reduce complexity and time-to-market by delivering high-quality products, with ingredients carefully selected from commonly used food ingredients or approved food additives that meet local regulatory requirements and support clean-label claims. This is all backed by Colorcon’s superior and dedicated technical support, along with regulatory expertise.
By Colorcon, Press Release
Source: colorcon.com
Novartis will acquire Mariana’s lead candidate MC-339, a radioligand therapy (RLT) designed to target small-cell lung cancer. Last year, Mariana had raised $175m in a Series B round from several funds and pharma giant Eli Lilly.
The company’s aspiration to expand the use of its obesity products to cardiovascular indications has been successful. In March, its blockbuster drug Wegovy was approved by the US Food and Drug Administration (FDA) for reducing the risk of cardiovascular diseases in obese or overweight adults.
Massachusetts-based Deciphera brings to the table an extensive kinase inhibitor pipeline, kinase drug discovery expertise, and a strong commercial and sales platform in the US and European markets that is meant to advance Ono’s capabilities and presence in the oncology space.
